Full-Time
Manager – Interface & Integration
Updated on 5/26/2026
BrightSpring Health Services
10,001+ employees
Home-based and community health services, pharmacy
No salary listed
Louisville, KY, USA
In Person
 Engineering Management (1) |
|---|
- Minimum of 5 years in application management, technical integrations, or related fields within healthcare, pharmacy, or health tech.
- Technical Knowledge: Strong understanding of third-party integrations, pharmacy and document management systems, and technologies like SSRS, BI, PowerShell, and data reporting solutions.
- Leadership: Proven ability to lead and develop a team, with strong organizational and project management skills.
- Analytical Skills: Detail-oriented with excellent problem-solving abilities, especially in the context of technical integrations and QA standards.
- Communication: Effective communicator with experience collaborating across departments and working with external vendors.
- To perform this position will require constantly sitting and typing on a keyboard with fingers, and frequently standing and walking. The physical requirements will be the ability to push/pull and lift/carry 1-10 lbs.
- Oversees the technical integration and quality assurance processes for all third-party interfaces, including eMAR systems, proprietary products integrated with PharMerica’s pharmacy and document management systems, and Cubex
- Ensures seamless interoperability between PharMerica’s core systems and third-party products, maintaining high performance, compliance, and user satisfaction
- Manages relationships with third-party vendors, collaborating closely to address any integration needs, troubleshoot issues, and ensure alignment with PharMerica’s application standards
- Leads all technical and QA activities associated with third-party integrations, defining standards, best practices, and protocols to ensure integration success and stability
- Works closely with the Development, Product and Implementation, Support, and QA teams to identify and resolve integration challenges, maintaining high-quality standards across all interfaces
- Performs regular reviews of integration performance and functionality, ensuring compliance with internal and regulatory standards
- Oversees the development and maintenance of SSRS and BI reporting solutions, ensuring they meet the needs of internal stakeholders and contribute to informed decision-making
- Collaborates with cross-functional teams to define reporting requirements, design solutions, and manage the reporting lifecycle from concept through deployment
- Maintains a continuous improvement mindset, optimizing existing reports and dashboards to deliver actionable insights
- Manages the development of internal tools and solutions, including PowerShell scripts, courier integrations, and other proprietary applications to support operational efficiency and team workflows
- Collaborates with stakeholders to identify new opportunities for automation, data analysis, and reporting, providing technical leadership to the team in implementing these initiatives
- Leads, mentors, and develops team members, fostering a culture of innovation, collaboration, and skill development in BI, integration management, and other relevant technologies
- Acts as the Interface and Integration Third-Party Applications primary liaison between the Application Management, and App Dev department. and other internal teams, as well as external vendors, ensuring alignment of technical requirements and project timelines
- Communicates regularly with the Senior Director of Application Management, providing updates on integration statuses, challenges, and project progress
- Collaborates with internal and external teams to resolve issues, gather requirements, and support strategic initiatives that require technical integration
- Ensures all third-party integrations and internal applications comply with PharMerica’s regulatory and security standards
- Monitors changes in industry standards and regulatory requirements, adjusting integrations and QA protocols as necessary
- Leads continuous improvement initiatives across third-party interfaces, reporting solutions, and internal development efforts to enhance quality, efficiency, and functionality
- Ensures seamless operation and high quality of third-party integrations and internal reporting solutions
- Maintains compliance and adapt integrations to meet evolving industry standards
- Provides regular updates to the Senior Director of Application Management on project progress and technical challenges
- Fosters a collaborative environment within the team, supporting innovation and skill development
BrightSpring Health Services provides home and community-based health care through two main operations: Pharmacy and Provider. In Pharmacy, it offers services for patients with complex and chronic conditions, including specialty, infusion, and community pharmacy solutions. In Provider, it delivers home health, behavioral health, hospice care, and services for intellectual and developmental disabilities. The company uses an integrated care model that connects pharmacy services with in-home care across its network to support patients, families, and managed care organizations. Revenue comes from reimbursed services paid by Medicare, Medicaid, and private insurers. Its goal is to coordinate ongoing, in-home and community-based care across a continuum—from pharmacy support to direct care—ensuring coordinated, patient-centered services for individuals with complex or chronic needs.
Company Size
10,001+
Company Stage
Post IPO Equity
Headquarters
Louisville, Kentucky
Founded
1974
Simplify's Take
What believers are saying
- Specialty and infusion revenue grew 35.5% year over year in Q1 2026.
- Amedisys and LHC integrations add about $30 million EBITDA in year one.
- Community living divestiture freed $811 million cash for higher-growth core services.
What critics are saying
- Medicare Part D cuts and brand-to-generic pressure create about $600 million headwinds.
- Home health acquisitions still require integration; clinician turnover would quickly erode margins.
- Government reimbursement and compliance exposure can hit pharmacy, hospice, and home health simultaneously.
What makes BrightSpring Health Services unique
- Integrated pharmacy and provider services target complex, chronic-care patients across home settings.
- National footprint spans behavioral health, home health, hospice, and intellectual disability services.
- Limited distribution drugs and specialty infusion deepen pharmacy differentiation and patient retention.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at BrightSpring Health Services who can refer or advise you
Benefits
Flexible Work Hours
Company News
BrightSpring Health Services announced the resignation of Robert Barnes as President of ResCare Community Living on 30 March 2026, stating it was not due to any disagreement over operations or policies. The company's shares rose 5.2% following upbeat analyst reports from its investor day. Management unveiled ambitious long-term organic EBITDA growth targets of 15% to 20% annually through 2028, alongside AI-driven efficiency plans for its home and community-based care platform. The narrative projects $16.8 billion in revenue and $361.8 million in earnings by 2028, requiring 10.1% yearly revenue growth. Investors remain focused on whether BrightSpring can balance acquisition-driven expansion and technology investment whilst managing its substantial debt load and regulatory exposure.
BrightSpring Health Services has seen its stock price surge 43.1% over the past six months to $42.32 per share, driven by strong quarterly results. The healthcare services company, founded in 1974, offers home health care, hospice, neuro-rehabilitation and pharmacy services. BrightSpring's revenue grew at an 18.3% compound annual growth rate over the past five years, outpacing the healthcare sector average. Analysts forecast 15% revenue growth over the next 12 months, though this represents a deceleration from its recent 20.9% annual rate. However, the company's five-year average return on invested capital of 4.9% falls below the typical cost of capital for healthcare firms, suggesting historically mediocre capital efficiency. The stock currently trades at 27.7× forward price-to-earnings ratio.
BrightSpring Health Services has raised questions about its valuation after trading at 24.5 times forward earnings following strong 2025 performance. The company reported fourth-quarter revenue of $3.55 billion, up 29.3% year-over-year, with adjusted EBITDA rising 40.7% to $184 million. For 2026, management guided revenue between $14.45 billion and $15 billion, representing 11.9% to 16.2% growth, whilst adjusted EBITDA is expected to grow faster at 23% to 28%, indicating margin expansion. However, the company faces approximately $600 million in revenue headwinds from Inflation Reduction Act impacts and brand-to-generic conversions. The valuation hinges on whether BrightSpring can deliver sequential profitability improvements throughout the year despite policy and product-mix pressures affecting headline revenue growth.
BrightSpring Health Services led senior health stocks in Q4 earnings, reporting revenues of $3.55 billion, up 16.3% year on year and beating analyst expectations by 5%. The company delivered strong full-year EBITDA guidance. In contrast, Chemed posted the weakest performance, with revenues of $639.3 million falling 3% short of expectations. The company missed both revenue and full-year EPS guidance estimates, sending shares down 19.2% to $377.07. The seven senior health, home health and hospice stocks tracked reported slower Q4 results overall, with revenues beating consensus estimates by just 1.1%. Share prices have declined an average of 9.6% since earnings releases. The sector faces headwinds from labour shortages and wage inflation whilst benefiting from an ageing population and growing preference for in-home care.
BrightSpring Health Services outlined its growth strategy at an investor day, highlighting a shift towards core home-and-community clinical services. The company's planned community-living divestiture will close soon to boost cash flow and support integrated care initiatives. BrightSpring reported significant deleveraging from approximately 4.5x post-IPO to 2.99x (2.6x pro forma), with leverage expected to fall below 2x in 2026. The company reiterated 2026 guidance of $14.45–$15.0 billion revenue and $760–$790 million adjusted EBITDA, whilst targeting 15–20% organic adjusted EBITDA compound annual growth for 2026–2028. The healthcare services provider has at least $2 billion available for acquisitions through 2028. Its operations include dispensing over 40 million prescriptions annually through PharMerica, serving more than 4 million patients, with recent branch integrations expected to add approximately $30 million of EBITDA.